D.Western Therapeutics Institute, Inc. (4576.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−6.4x

Market Cap

JPY 4.85B

MomentumView details →

1D Return

−1.16%

YTD Return

−9.38%

RSI (14)

58.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−6.4x

Market Cap

JPY 4.85B

RSI (14)

58.8

MomentumView details →

1D Return

−1.16%

YTD Return

−9.38%

ProfitabilityView details →

Gross Margin

90.12%

Net Margin

−163.31%

EBITDA Margin

−147.67%

ROE (TTM)

−44.04%

ROA (TTM)

−29.14%

Asset Turnover

0.18x

GrowthView details →

Revenue YoY

−17.83%

EPS YoY

+63.81%

FCF YoY

—

Revenue CAGR 3Y

−4.76%

EPS CAGR 3Y

+64.10%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.42x

Current Ratio

9.91x

Quick Ratio

9.91x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

306.00M

Net Income (TTM)

−652.00M

Op. CF (TTM)

—

Next earningsNov 5, 2026 →

Latest newsMore news →

De Western Therapeutics received a patent allowance for its glaucoma treatment 'H-1337' under development in Canada.18d ago

Similar companies

TMS Co.,Ltd.4891.T Chordia Therapeutics Inc.190A.T Cyfuse Biomedical K.K.4892.T RIBOMIC Inc.4591.T Chiome Bioscience Inc.4583.T NIPPON CHEMIPHAR CO.,LTD.4539.T Find similar companies →

Latest newsMore news →

De Western Therapeutics received a patent allowance for its glaucoma treatment 'H-1337' under development in Canada.18d ago